Pharma & Healthcare
Global Quetiapine Fumarate Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 304074
- Pages: 150
- Figures: 150
- Views: 1
In 2024, the global market size of Quetiapine Fumarate was estimated to be worth US$ 153 million and is forecast to reach approximately US$ 131 million by 2031 with a CAGR of -2.2% during the forecast period 2025-2031.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy"s, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate.
The Quetiapine Fumarate market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Quetiapine Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quetiapine Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Segment by Type
Immediate Release Tablets
Extended Release Tablets
Segment by Application
Adult
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Quetiapine Fumarate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Quetiapine Fumarate sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy"s, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate.
The Quetiapine Fumarate market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Quetiapine Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quetiapine Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Segment by Type
Immediate Release Tablets
Extended Release Tablets
Segment by Application
Adult
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Quetiapine Fumarate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Quetiapine Fumarate sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Quetiapine Fumarate Product Introduction
1.2 Market by Type
1.2.1 Global Quetiapine Fumarate Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Adult
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Quetiapine Fumarate Market Size Estimates and Forecasts
2.1.1 Global Quetiapine Fumarate Revenue 2020-2031
2.1.2 Global Quetiapine Fumarate Sales 2020-2031
2.2 Quetiapine Fumarate Market Size by Region: 2024 Versus 2031
2.3 Quetiapine Fumarate Sales by Region (2020-2031)
2.3.1 Global Quetiapine Fumarate Sales by Region: 2020-2025
2.3.2 Global Quetiapine Fumarate Sales Forecast by Region (2026-2031)
2.3.3 Global Quetiapine Fumarate Sales Market Share by Region (2020-2031)
2.4 Quetiapine Fumarate Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Quetiapine Fumarate Revenue by Region: 2020-2025
2.4.2 Global Quetiapine Fumarate Revenue Forecast by Region (2026-2031)
2.4.3 Global Quetiapine Fumarate Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Quetiapine Fumarate Sales by Type (2020-2031)
3.1.1.1 Global Quetiapine Fumarate Sales Volume by Type (2020-2031)
3.1.1.2 Global Quetiapine Fumarate Sales Market Share by Type (2020-2031)
3.1.2 Global Quetiapine Fumarate Revenue by Type (2020-2031)
3.1.2.1 Global Quetiapine Fumarate Revenue by Type (2020-2031)
3.1.2.2 Global Quetiapine Fumarate Revenue Market Share by Type (2020-2031)
3.1.3 Quetiapine Fumarate Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Quetiapine Fumarate Sales by Application (2020-2031)
3.2.1.1 Global Quetiapine Fumarate Sales Volume by Application (2020-2031)
3.2.1.2 Global Quetiapine Fumarate Sales Market Share by Application (2020-2031)
3.2.2 Global Quetiapine Fumarate Revenue by Application (2020-2031)
3.2.2.1 Global Quetiapine Fumarate Revenue by Application (2020-2031)
3.2.2.2 Global Quetiapine Fumarate Revenue Market Share by Application (2020-2031)
3.2.3 Quetiapine Fumarate Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Immediate Release Tablets of Quetiapine Fumarate Revenue Market Share by Application
3.3.2 Extended Release Tablets of Quetiapine Fumarate Revenue Market Share by Application
4 Global Quetiapine Fumarate by Manufacturers
4.1 Global Top Quetiapine Fumarate Manufacturers by Sales (2020-2025)
4.1.1 Global Quetiapine Fumarate Sales by Manufacturer (2020-2025)
4.1.2 Global Quetiapine Fumarate Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Quetiapine Fumarate Manufacturers by Revenue (2020-2025)
4.2.1 Global Quetiapine Fumarate Revenue by Manufacturer (2020-2025)
4.2.2 Global Quetiapine Fumarate Revenue Share by Manufacturer (2020-2025)
4.3 Global Quetiapine Fumarate Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Quetiapine Fumarate Manufacturers Covered: Ranking by Revenue
4.4.2 Global Quetiapine Fumarate Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Quetiapine Fumarate Manufacturing Base Distribution, Product Type
4.5.1 Quetiapine Fumarate Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Quetiapine Fumarate Market
4.5.3 Manufacturers Quetiapine Fumarate Product Type and Application
4.5.4 Immediate Release Tablets Market Sales of Quetiapine Fumarate by Manufacturer
4.5.5 Extended Release Tablets Market Sales of Quetiapine Fumarate by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Company Information
5.1.2 AstraZeneca Description, Business Overview
5.1.3 AstraZeneca Quetiapine Fumarate Products Offered
5.1.4 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.1.5 AstraZeneca Quetiapine Fumarate Sales by Product in 2024
5.1.6 AstraZeneca Quetiapine Fumarate Sales by Application in 2024
5.1.7 AstraZeneca Quetiapine Fumarate Sales by Geographic Area in 2024
5.1.8 AstraZeneca Recent Developments
5.2 Intas
5.2.1 Intas Company Information
5.2.2 Intas Description, Business Overview
5.2.3 Intas Quetiapine Fumarate Products Offered
5.2.4 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Intas Quetiapine Fumarate Sales by Product in 2024
5.2.6 Intas Quetiapine Fumarate Sales by Application in 2024
5.2.7 Intas Quetiapine Fumarate Sales by Geographic Area in 2024
5.2.8 Intas Recent Developments
5.3 TAPI
5.3.1 TAPI Company Information
5.3.2 TAPI Description, Business Overview
5.3.3 TAPI Quetiapine Fumarate Products Offered
5.3.4 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.3.5 TAPI Quetiapine Fumarate Sales by Product in 2024
5.3.6 TAPI Quetiapine Fumarate Sales by Application in 2024
5.3.7 TAPI Quetiapine Fumarate Sales by Geographic Area in 2024
5.3.8 TAPI Recent Developments
5.4 Accord
5.4.1 Accord Company Information
5.4.2 Accord Description, Business Overview
5.4.3 Accord Quetiapine Fumarate Products Offered
5.4.4 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Accord Quetiapine Fumarate Sales by Product in 2024
5.4.6 Accord Quetiapine Fumarate Sales by Application in 2024
5.4.7 Accord Quetiapine Fumarate Sales by Geographic Area in 2024
5.4.8 Accord Recent Developments
5.5 Hexal
5.5.1 Hexal Company Information
5.5.2 Hexal Description, Business Overview
5.5.3 Hexal Quetiapine Fumarate Products Offered
5.5.4 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Hexal Quetiapine Fumarate Sales by Product in 2024
5.5.6 Hexal Quetiapine Fumarate Sales by Application in 2024
5.5.7 Hexal Quetiapine Fumarate Sales by Geographic Area in 2024
5.5.8 Hexal Recent Developments
5.6 Dr.Reddy's
5.6.1 Dr.Reddy's Company Information
5.6.2 Dr.Reddy's Description, Business Overview
5.6.3 Dr.Reddy's Quetiapine Fumarate Products Offered
5.6.4 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Dr.Reddy's Quetiapine Fumarate Sales by Product in 2024
5.6.6 Dr.Reddy's Quetiapine Fumarate Sales by Application in 2024
5.6.7 Dr.Reddy's Quetiapine Fumarate Sales by Geographic Area in 2024
5.6.8 Dr.Reddy's Recent Developments
5.7 Lupin
5.7.1 Lupin Company Information
5.7.2 Lupin Description, Business Overview
5.7.3 Lupin Quetiapine Fumarate Products Offered
5.7.4 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Lupin Quetiapine Fumarate Sales by Product in 2024
5.7.6 Lupin Quetiapine Fumarate Sales by Application in 2024
5.7.7 Lupin Quetiapine Fumarate Sales by Geographic Area in 2024
5.7.8 Lupin Recent Developments
5.8 Sun Pharmaceutical
5.8.1 Sun Pharmaceutical Company Information
5.8.2 Sun Pharmaceutical Description, Business Overview
5.8.3 Sun Pharmaceutical Quetiapine Fumarate Products Offered
5.8.4 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Sun Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.8.6 Sun Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.8.7 Sun Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.8.8 Sun Pharmaceutical Recent Developments
5.9 Hunan Dongting Pharm
5.9.1 Hunan Dongting Pharm Company Information
5.9.2 Hunan Dongting Pharm Description, Business Overview
5.9.3 Hunan Dongting Pharm Quetiapine Fumarate Products Offered
5.9.4 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Hunan Dongting Pharm Quetiapine Fumarate Sales by Product in 2024
5.9.6 Hunan Dongting Pharm Quetiapine Fumarate Sales by Application in 2024
5.9.7 Hunan Dongting Pharm Quetiapine Fumarate Sales by Geographic Area in 2024
5.9.8 Hunan Dongting Pharm Recent Developments
5.10 SuZhou NO.4 Phamaceutical Factory
5.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
5.10.2 SuZhou NO.4 Phamaceutical Factory Description, Business Overview
5.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Products Offered
5.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.10.5 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Product in 2024
5.10.6 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Application in 2024
5.10.7 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Geographic Area in 2024
5.10.8 SuZhou NO.4 Phamaceutical Factory Recent Developments
5.11 Fuan Pharmaceutical
5.11.1 Fuan Pharmaceutical Company Information
5.11.2 Fuan Pharmaceutical Description, Business Overview
5.11.3 Fuan Pharmaceutical Quetiapine Fumarate Products Offered
5.11.4 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Fuan Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.11.6 Fuan Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.11.7 Fuan Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.11.8 Fuan Pharmaceutical Recent Developments
5.12 Zhejiang Supor Pharmaceuticals
5.12.1 Zhejiang Supor Pharmaceuticals Company Information
5.12.2 Zhejiang Supor Pharmaceuticals Description, Business Overview
5.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Products Offered
5.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Product in 2024
5.12.6 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Application in 2024
5.12.7 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Geographic Area in 2024
5.12.8 Zhejiang Supor Pharmaceuticals Recent Developments
5.13 Zhejiang Huahai Pharmaceutical
5.13.1 Zhejiang Huahai Pharmaceutical Company Information
5.13.2 Zhejiang Huahai Pharmaceutical Description, Business Overview
5.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Products Offered
5.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.13.6 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.13.7 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.13.8 Zhejiang Huahai Pharmaceutical Recent Developments
6 North America
6.1 North America Quetiapine Fumarate Market Size YoY Growth 2020-2031
6.2 North America Quetiapine Fumarate Market Facts & Figures by Country
6.2.1 North America Quetiapine Fumarate Sales by Country (2020-2031)
6.2.2 North America Quetiapine Fumarate Revenue by Country (2020-2031)
6.3 North America Quetiapine Fumarate Sales by Type (2020-2025)
6.4 North America Quetiapine Fumarate Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Quetiapine Fumarate Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Quetiapine Fumarate Market Facts & Figures by Region
7.2.1 Asia-Pacific Quetiapine Fumarate Sales by Region (2020-2031)
7.2.2 Asia-Pacific Quetiapine Fumarate Revenue by Region (2020-2031)
7.3 Asia-Pacific Quetiapine Fumarate Sales by Type (2020-2025)
7.4 Asia-Pacific Quetiapine Fumarate Sales by Application (2020-2025)
8 Europe
8.1 Europe Quetiapine Fumarate Market Size YoY Growth 2020-2031
8.2 Europe Quetiapine Fumarate Market Facts & Figures by Country
8.2.1 Europe Quetiapine Fumarate Sales by Country (2020-2031)
8.2.2 Europe Quetiapine Fumarate Revenue by Country (2020-2031)
8.3 Europe Quetiapine Fumarate Sales by Type (2020-2025)
8.4 Europe Quetiapine Fumarate Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2020-2031
9.2 Latin America Quetiapine Fumarate Market Facts & Figures by Country
9.2.1 Latin America Quetiapine Fumarate Sales by Country (2020-2031)
9.2.2 Latin America Quetiapine Fumarate Revenue by Country (2020-2031)
9.3 Latin America Quetiapine Fumarate Sales by Type (2020-2025)
9.4 Latin America Quetiapine Fumarate Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
10.2.1 Middle East and Africa Quetiapine Fumarate Sales by Country (2020-2031)
10.2.2 Middle East and Africa Quetiapine Fumarate Revenue by Country (2020-2031)
10.3 Middle East and Africa Quetiapine Fumarate Sales by Type (2020-2025)
10.4 Middle East and Africa Quetiapine Fumarate Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Quetiapine Fumarate Supply Chain Analysis
11.2 Quetiapine Fumarate Key Raw Materials and Upstream Suppliers
11.3 Quetiapine Fumarate Clients Analysis
11.4 Quetiapine Fumarate Sales Channel and Sales Model Analysis
11.4.1 Quetiapine Fumarate Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Quetiapine Fumarate Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Quetiapine Fumarate Distributors
12 Quetiapine Fumarate Market Dynamics
12.1 Quetiapine Fumarate Industry Trends
12.2 Quetiapine Fumarate Market Drivers
12.3 Quetiapine Fumarate Market Challenges
12.4 Quetiapine Fumarate Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Quetiapine Fumarate Product Introduction
1.2 Market by Type
1.2.1 Global Quetiapine Fumarate Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Adult
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Quetiapine Fumarate Market Size Estimates and Forecasts
2.1.1 Global Quetiapine Fumarate Revenue 2020-2031
2.1.2 Global Quetiapine Fumarate Sales 2020-2031
2.2 Quetiapine Fumarate Market Size by Region: 2024 Versus 2031
2.3 Quetiapine Fumarate Sales by Region (2020-2031)
2.3.1 Global Quetiapine Fumarate Sales by Region: 2020-2025
2.3.2 Global Quetiapine Fumarate Sales Forecast by Region (2026-2031)
2.3.3 Global Quetiapine Fumarate Sales Market Share by Region (2020-2031)
2.4 Quetiapine Fumarate Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Quetiapine Fumarate Revenue by Region: 2020-2025
2.4.2 Global Quetiapine Fumarate Revenue Forecast by Region (2026-2031)
2.4.3 Global Quetiapine Fumarate Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Quetiapine Fumarate Sales by Type (2020-2031)
3.1.1.1 Global Quetiapine Fumarate Sales Volume by Type (2020-2031)
3.1.1.2 Global Quetiapine Fumarate Sales Market Share by Type (2020-2031)
3.1.2 Global Quetiapine Fumarate Revenue by Type (2020-2031)
3.1.2.1 Global Quetiapine Fumarate Revenue by Type (2020-2031)
3.1.2.2 Global Quetiapine Fumarate Revenue Market Share by Type (2020-2031)
3.1.3 Quetiapine Fumarate Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Quetiapine Fumarate Sales by Application (2020-2031)
3.2.1.1 Global Quetiapine Fumarate Sales Volume by Application (2020-2031)
3.2.1.2 Global Quetiapine Fumarate Sales Market Share by Application (2020-2031)
3.2.2 Global Quetiapine Fumarate Revenue by Application (2020-2031)
3.2.2.1 Global Quetiapine Fumarate Revenue by Application (2020-2031)
3.2.2.2 Global Quetiapine Fumarate Revenue Market Share by Application (2020-2031)
3.2.3 Quetiapine Fumarate Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Immediate Release Tablets of Quetiapine Fumarate Revenue Market Share by Application
3.3.2 Extended Release Tablets of Quetiapine Fumarate Revenue Market Share by Application
4 Global Quetiapine Fumarate by Manufacturers
4.1 Global Top Quetiapine Fumarate Manufacturers by Sales (2020-2025)
4.1.1 Global Quetiapine Fumarate Sales by Manufacturer (2020-2025)
4.1.2 Global Quetiapine Fumarate Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Quetiapine Fumarate Manufacturers by Revenue (2020-2025)
4.2.1 Global Quetiapine Fumarate Revenue by Manufacturer (2020-2025)
4.2.2 Global Quetiapine Fumarate Revenue Share by Manufacturer (2020-2025)
4.3 Global Quetiapine Fumarate Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Quetiapine Fumarate Manufacturers Covered: Ranking by Revenue
4.4.2 Global Quetiapine Fumarate Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Quetiapine Fumarate Manufacturing Base Distribution, Product Type
4.5.1 Quetiapine Fumarate Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Quetiapine Fumarate Market
4.5.3 Manufacturers Quetiapine Fumarate Product Type and Application
4.5.4 Immediate Release Tablets Market Sales of Quetiapine Fumarate by Manufacturer
4.5.5 Extended Release Tablets Market Sales of Quetiapine Fumarate by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Company Information
5.1.2 AstraZeneca Description, Business Overview
5.1.3 AstraZeneca Quetiapine Fumarate Products Offered
5.1.4 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.1.5 AstraZeneca Quetiapine Fumarate Sales by Product in 2024
5.1.6 AstraZeneca Quetiapine Fumarate Sales by Application in 2024
5.1.7 AstraZeneca Quetiapine Fumarate Sales by Geographic Area in 2024
5.1.8 AstraZeneca Recent Developments
5.2 Intas
5.2.1 Intas Company Information
5.2.2 Intas Description, Business Overview
5.2.3 Intas Quetiapine Fumarate Products Offered
5.2.4 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Intas Quetiapine Fumarate Sales by Product in 2024
5.2.6 Intas Quetiapine Fumarate Sales by Application in 2024
5.2.7 Intas Quetiapine Fumarate Sales by Geographic Area in 2024
5.2.8 Intas Recent Developments
5.3 TAPI
5.3.1 TAPI Company Information
5.3.2 TAPI Description, Business Overview
5.3.3 TAPI Quetiapine Fumarate Products Offered
5.3.4 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.3.5 TAPI Quetiapine Fumarate Sales by Product in 2024
5.3.6 TAPI Quetiapine Fumarate Sales by Application in 2024
5.3.7 TAPI Quetiapine Fumarate Sales by Geographic Area in 2024
5.3.8 TAPI Recent Developments
5.4 Accord
5.4.1 Accord Company Information
5.4.2 Accord Description, Business Overview
5.4.3 Accord Quetiapine Fumarate Products Offered
5.4.4 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Accord Quetiapine Fumarate Sales by Product in 2024
5.4.6 Accord Quetiapine Fumarate Sales by Application in 2024
5.4.7 Accord Quetiapine Fumarate Sales by Geographic Area in 2024
5.4.8 Accord Recent Developments
5.5 Hexal
5.5.1 Hexal Company Information
5.5.2 Hexal Description, Business Overview
5.5.3 Hexal Quetiapine Fumarate Products Offered
5.5.4 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Hexal Quetiapine Fumarate Sales by Product in 2024
5.5.6 Hexal Quetiapine Fumarate Sales by Application in 2024
5.5.7 Hexal Quetiapine Fumarate Sales by Geographic Area in 2024
5.5.8 Hexal Recent Developments
5.6 Dr.Reddy's
5.6.1 Dr.Reddy's Company Information
5.6.2 Dr.Reddy's Description, Business Overview
5.6.3 Dr.Reddy's Quetiapine Fumarate Products Offered
5.6.4 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Dr.Reddy's Quetiapine Fumarate Sales by Product in 2024
5.6.6 Dr.Reddy's Quetiapine Fumarate Sales by Application in 2024
5.6.7 Dr.Reddy's Quetiapine Fumarate Sales by Geographic Area in 2024
5.6.8 Dr.Reddy's Recent Developments
5.7 Lupin
5.7.1 Lupin Company Information
5.7.2 Lupin Description, Business Overview
5.7.3 Lupin Quetiapine Fumarate Products Offered
5.7.4 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Lupin Quetiapine Fumarate Sales by Product in 2024
5.7.6 Lupin Quetiapine Fumarate Sales by Application in 2024
5.7.7 Lupin Quetiapine Fumarate Sales by Geographic Area in 2024
5.7.8 Lupin Recent Developments
5.8 Sun Pharmaceutical
5.8.1 Sun Pharmaceutical Company Information
5.8.2 Sun Pharmaceutical Description, Business Overview
5.8.3 Sun Pharmaceutical Quetiapine Fumarate Products Offered
5.8.4 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Sun Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.8.6 Sun Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.8.7 Sun Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.8.8 Sun Pharmaceutical Recent Developments
5.9 Hunan Dongting Pharm
5.9.1 Hunan Dongting Pharm Company Information
5.9.2 Hunan Dongting Pharm Description, Business Overview
5.9.3 Hunan Dongting Pharm Quetiapine Fumarate Products Offered
5.9.4 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Hunan Dongting Pharm Quetiapine Fumarate Sales by Product in 2024
5.9.6 Hunan Dongting Pharm Quetiapine Fumarate Sales by Application in 2024
5.9.7 Hunan Dongting Pharm Quetiapine Fumarate Sales by Geographic Area in 2024
5.9.8 Hunan Dongting Pharm Recent Developments
5.10 SuZhou NO.4 Phamaceutical Factory
5.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
5.10.2 SuZhou NO.4 Phamaceutical Factory Description, Business Overview
5.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Products Offered
5.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.10.5 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Product in 2024
5.10.6 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Application in 2024
5.10.7 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Geographic Area in 2024
5.10.8 SuZhou NO.4 Phamaceutical Factory Recent Developments
5.11 Fuan Pharmaceutical
5.11.1 Fuan Pharmaceutical Company Information
5.11.2 Fuan Pharmaceutical Description, Business Overview
5.11.3 Fuan Pharmaceutical Quetiapine Fumarate Products Offered
5.11.4 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Fuan Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.11.6 Fuan Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.11.7 Fuan Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.11.8 Fuan Pharmaceutical Recent Developments
5.12 Zhejiang Supor Pharmaceuticals
5.12.1 Zhejiang Supor Pharmaceuticals Company Information
5.12.2 Zhejiang Supor Pharmaceuticals Description, Business Overview
5.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Products Offered
5.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Product in 2024
5.12.6 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Application in 2024
5.12.7 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Geographic Area in 2024
5.12.8 Zhejiang Supor Pharmaceuticals Recent Developments
5.13 Zhejiang Huahai Pharmaceutical
5.13.1 Zhejiang Huahai Pharmaceutical Company Information
5.13.2 Zhejiang Huahai Pharmaceutical Description, Business Overview
5.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Products Offered
5.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.13.6 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.13.7 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.13.8 Zhejiang Huahai Pharmaceutical Recent Developments
6 North America
6.1 North America Quetiapine Fumarate Market Size YoY Growth 2020-2031
6.2 North America Quetiapine Fumarate Market Facts & Figures by Country
6.2.1 North America Quetiapine Fumarate Sales by Country (2020-2031)
6.2.2 North America Quetiapine Fumarate Revenue by Country (2020-2031)
6.3 North America Quetiapine Fumarate Sales by Type (2020-2025)
6.4 North America Quetiapine Fumarate Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Quetiapine Fumarate Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Quetiapine Fumarate Market Facts & Figures by Region
7.2.1 Asia-Pacific Quetiapine Fumarate Sales by Region (2020-2031)
7.2.2 Asia-Pacific Quetiapine Fumarate Revenue by Region (2020-2031)
7.3 Asia-Pacific Quetiapine Fumarate Sales by Type (2020-2025)
7.4 Asia-Pacific Quetiapine Fumarate Sales by Application (2020-2025)
8 Europe
8.1 Europe Quetiapine Fumarate Market Size YoY Growth 2020-2031
8.2 Europe Quetiapine Fumarate Market Facts & Figures by Country
8.2.1 Europe Quetiapine Fumarate Sales by Country (2020-2031)
8.2.2 Europe Quetiapine Fumarate Revenue by Country (2020-2031)
8.3 Europe Quetiapine Fumarate Sales by Type (2020-2025)
8.4 Europe Quetiapine Fumarate Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2020-2031
9.2 Latin America Quetiapine Fumarate Market Facts & Figures by Country
9.2.1 Latin America Quetiapine Fumarate Sales by Country (2020-2031)
9.2.2 Latin America Quetiapine Fumarate Revenue by Country (2020-2031)
9.3 Latin America Quetiapine Fumarate Sales by Type (2020-2025)
9.4 Latin America Quetiapine Fumarate Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
10.2.1 Middle East and Africa Quetiapine Fumarate Sales by Country (2020-2031)
10.2.2 Middle East and Africa Quetiapine Fumarate Revenue by Country (2020-2031)
10.3 Middle East and Africa Quetiapine Fumarate Sales by Type (2020-2025)
10.4 Middle East and Africa Quetiapine Fumarate Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Quetiapine Fumarate Supply Chain Analysis
11.2 Quetiapine Fumarate Key Raw Materials and Upstream Suppliers
11.3 Quetiapine Fumarate Clients Analysis
11.4 Quetiapine Fumarate Sales Channel and Sales Model Analysis
11.4.1 Quetiapine Fumarate Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Quetiapine Fumarate Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Quetiapine Fumarate Distributors
12 Quetiapine Fumarate Market Dynamics
12.1 Quetiapine Fumarate Industry Trends
12.2 Quetiapine Fumarate Market Drivers
12.3 Quetiapine Fumarate Market Challenges
12.4 Quetiapine Fumarate Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Quetiapine Fumarate Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Quetiapine Fumarate Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Quetiapine Fumarate Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Quetiapine Fumarate Sales by Region (2020-2025) & (MT)
Table 5. Global Quetiapine Fumarate Sales Forecast by Region (2026-2031) & (MT)
Table 6. Global Quetiapine Fumarate Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Quetiapine Fumarate Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Quetiapine Fumarate Sales Volume by Type (2020-2025) & (MT)
Table 9. Global Quetiapine Fumarate Sales Volume by Type (2026-2031) & (MT)
Table 10. Global Quetiapine Fumarate Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Quetiapine Fumarate Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Quetiapine Fumarate Sales Volume by Application (2020-2025) & (MT)
Table 13. Global Quetiapine Fumarate Sales Volume by Application (2026-2031) & (MT)
Table 14. Global Quetiapine Fumarate Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Quetiapine Fumarate Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Quetiapine Fumarate Sales by Manufacturer (2020-2025) & (MT)
Table 17. Global Quetiapine Fumarate Sales Share by Manufacturer (2020-2025)
Table 18. Quetiapine Fumarate Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Quetiapine Fumarate Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Quetiapine Fumarate Price (2020-2025) & (USD/Kg)
Table 21. Ranking of Global Top Quetiapine Fumarate Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Quetiapine Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Quetiapine Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quetiapine Fumarate as of 2024)
Table 24. Quetiapine Fumarate Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Quetiapine Fumarate Market
Table 26. Manufacturers Quetiapine Fumarate Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. AstraZeneca Company Information
Table 29. AstraZeneca Description and Business Overview
Table 30. AstraZeneca Quetiapine Fumarate Product
Table 31. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 32. AstraZeneca Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 33. AstraZeneca Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 34. AstraZeneca Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 35. AstraZeneca Recent Developments
Table 36. Intas Company Information
Table 37. Intas Description and Business Overview
Table 38. Intas Quetiapine Fumarate Product
Table 39. Intas Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 40. Intas Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 41. Intas Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 42. Intas Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 43. Intas Recent Developments
Table 44. TAPI Company Information
Table 45. TAPI Description and Business Overview
Table 46. TAPI Quetiapine Fumarate Product
Table 47. TAPI Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 48. TAPI Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 49. TAPI Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 50. TAPI Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 51. TAPI Recent Developments
Table 52. Accord Company Information
Table 53. Accord Description and Business Overview
Table 54. Accord Quetiapine Fumarate Product
Table 55. Accord Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 56. Accord Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 57. Accord Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 58. Accord Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 59. Accord Recent Developments
Table 60. Hexal Company Information
Table 61. Hexal Description and Business Overview
Table 62. Hexal Quetiapine Fumarate Product
Table 63. Hexal Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 64. Hexal Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 65. Hexal Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 66. Hexal Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 67. Hexal Recent Developments
Table 68. Dr.Reddy's Company Information
Table 69. Dr.Reddy's Description and Business Overview
Table 70. Dr.Reddy's Quetiapine Fumarate Product
Table 71. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 72. Dr.Reddy's Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 73. Dr.Reddy's Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 74. Dr.Reddy's Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 75. Dr.Reddy's Recent Developments
Table 76. Lupin Company Information
Table 77. Lupin Description and Business Overview
Table 78. Lupin Quetiapine Fumarate Product
Table 79. Lupin Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Lupin Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 81. Lupin Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 82. Lupin Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 83. Lupin Recent Developments
Table 84. Sun Pharmaceutical Company Information
Table 85. Sun Pharmaceutical Description and Business Overview
Table 86. Sun Pharmaceutical Quetiapine Fumarate Product
Table 87. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Sun Pharmaceutical Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 89. Sun Pharmaceutical Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 90. Sun Pharmaceutical Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 91. Sun Pharmaceutical Recent Developments
Table 92. Hunan Dongting Pharm Company Information
Table 93. Hunan Dongting Pharm Description and Business Overview
Table 94. Hunan Dongting Pharm Quetiapine Fumarate Product
Table 95. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 96. Hunan Dongting Pharm Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 97. Hunan Dongting Pharm Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 98. Hunan Dongting Pharm Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 99. Hunan Dongting Pharm Recent Developments
Table 100. SuZhou NO.4 Phamaceutical Factory Company Information
Table 101. SuZhou NO.4 Phamaceutical Factory Description and Business Overview
Table 102. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product
Table 103. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 104. SuZhou NO.4 Phamaceutical Factory Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 105. SuZhou NO.4 Phamaceutical Factory Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 106. SuZhou NO.4 Phamaceutical Factory Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 107. SuZhou NO.4 Phamaceutical Factory Recent Developments
Table 108. Fuan Pharmaceutical Company Information
Table 109. Fuan Pharmaceutical Description and Business Overview
Table 110. Fuan Pharmaceutical Quetiapine Fumarate Product
Table 111. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 112. Fuan Pharmaceutical Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 113. Fuan Pharmaceutical Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 114. Fuan Pharmaceutical Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 115. Fuan Pharmaceutical Recent Developments
Table 116. Zhejiang Supor Pharmaceuticals Company Information
Table 117. Zhejiang Supor Pharmaceuticals Description and Business Overview
Table 118. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product
Table 119. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Zhejiang Supor Pharmaceuticals Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 121. Zhejiang Supor Pharmaceuticals Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 122. Zhejiang Supor Pharmaceuticals Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 123. Zhejiang Supor Pharmaceuticals Recent Developments
Table 124. Zhejiang Huahai Pharmaceutical Company Information
Table 125. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 126. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product
Table 127. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Zhejiang Huahai Pharmaceutical Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 129. Zhejiang Huahai Pharmaceutical Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 130. Zhejiang Huahai Pharmaceutical Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 131. Zhejiang Huahai Pharmaceutical Recent Developments
Table 132. North America Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 133. North America Quetiapine Fumarate Sales by Country (2026-2031) & (MT)
Table 134. North America Quetiapine Fumarate Revenue by Country (2020-2025) & (US$ Million)
Table 135. North America Quetiapine Fumarate Revenue by Country (2026-2031) & (US$ Million)
Table 136. North America Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 137. North America Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 138. Asia-Pacific Quetiapine Fumarate Sales by Region (2020-2025) & (MT)
Table 139. Asia-Pacific Quetiapine Fumarate Sales by Region (2026-2031) & (MT)
Table 140. Asia-Pacific Quetiapine Fumarate Revenue by Region (2020-2025) & (US$ Million)
Table 141. Asia-Pacific Quetiapine Fumarate Revenue by Region (2026-2031) & (US$ Million)
Table 142. Asia-Pacific Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 143. Asia-Pacific Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 144. Europe Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 145. Europe Quetiapine Fumarate Sales by Country (2026-2031) & (MT)
Table 146. Europe Quetiapine Fumarate Revenue by Country (2020-2025) & (US$ Million)
Table 147. Europe Quetiapine Fumarate Revenue by Country (2026-2031) & (US$ Million)
Table 148. Europe Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 149. Europe Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 150. Latin America Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 151. Latin America Quetiapine Fumarate Sales by Country (2026-2031) & (MT)
Table 152. Latin America Quetiapine Fumarate Revenue by Country (2020-2025) & (US$ Million)
Table 153. Latin America Quetiapine Fumarate Revenue by Country (2026-2031) & (US$ Million)
Table 154. Latin America Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 155. Latin America Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 156. Middle East and Africa Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 157. Middle East and Africa Quetiapine Fumarate Sales by Country (2026-2031) & (MT)
Table 158. Middle East and Africa Quetiapine Fumarate Revenue by Country (2020-2025) & (US$ Million)
Table 159. Middle East and Africa Quetiapine Fumarate Revenue by Country (2026-2031) & (US$ Million)
Table 160. Middle East and Africa Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 161. Middle East and Africa Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 162. Quetiapine Fumarate Key Raw Materials, Industry Status and Trend
Table 163. Quetiapine Fumarate Key Raw Materials and Upstream Suppliers
Table 164. Quetiapine Fumarate Clients Status and Trend
Table 165. Quetiapine Fumarate Typical Clients
Table 166. Quetiapine Fumarate Distributors
Table 167. Quetiapine Fumarate Market Trends
Table 168. Quetiapine Fumarate Market Drivers
Table 169. Quetiapine Fumarate Market Challenges
Table 170. Quetiapine Fumarate Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Quetiapine Fumarate Product Picture
Figure 2. Global Quetiapine Fumarate Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Quetiapine Fumarate Sales Market Share by Type in 2024 & 2031
Figure 4. Immediate Release Tablets Product Picture
Figure 5. Extended Release Tablets Product Picture
Figure 6. Global Quetiapine Fumarate Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Quetiapine Fumarate Sales Market Share by Application in 2024 & 2031
Figure 8. Adult
Figure 9. Others
Figure 10. Quetiapine Fumarate Report Years Considered
Figure 11. Global Quetiapine Fumarate Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Quetiapine Fumarate Market Size 2020-2031 (US$ Million)
Figure 13. Global Quetiapine Fumarate Sales 2020-2031 (MT)
Figure 14. Global Quetiapine Fumarate Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Quetiapine Fumarate Revenue Market Share by Region (2020-2031)
Figure 16. Global Quetiapine Fumarate Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Quetiapine Fumarate Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Quetiapine Fumarate Average Selling Price (ASP) by Type (2020-2025) & (USD/Kg)
Figure 19. Global Quetiapine Fumarate Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Quetiapine Fumarate Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Quetiapine Fumarate Average Selling Price (ASP) by Application (2020-2025) & (USD/Kg)
Figure 22. Immediate Release Tablets of Quetiapine Fumarate Revenue Market Share by Application, 2024 VS 2031
Figure 23. Extended Release Tablets of Quetiapine Fumarate Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Quetiapine Fumarate Sales Share by Manufacturer in 2024
Figure 25. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Immediate Release Tablets Market Sales Proportion by Manufacturer in 2024
Figure 27. Extended Release Tablets Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Quetiapine Fumarate Revenue 2020-2031 (US$ Million)
Figure 29. North America Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 30. North America Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Quetiapine Fumarate Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Quetiapine Fumarate Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Quetiapine Fumarate Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 36. Europe Quetiapine Fumarate Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Quetiapine Fumarate Sales Market Share by Country (2020-2031)
Figure 38. Europe Quetiapine Fumarate Revenue Market Share by Country (2020-2031)
Figure 39. Europe Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 40. Europe Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 41. Latin America Quetiapine Fumarate Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Quetiapine Fumarate Sales Market Share by Country (2020-2031)
Figure 43. Latin America Quetiapine Fumarate Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 45. Latin America Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Quetiapine Fumarate Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Quetiapine Fumarate Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Quetiapine Fumarate Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 51. Quetiapine Fumarate Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Quetiapine Fumarate Raw Materials by Region in 2024
Figure 53. Quetiapine Fumarate Distribution Channels
Figure 54. Global Quetiapine Fumarate Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Quetiapine Fumarate Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Quetiapine Fumarate Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Quetiapine Fumarate Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Quetiapine Fumarate Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Quetiapine Fumarate Sales by Region (2020-2025) & (MT)
Table 5. Global Quetiapine Fumarate Sales Forecast by Region (2026-2031) & (MT)
Table 6. Global Quetiapine Fumarate Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Quetiapine Fumarate Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Quetiapine Fumarate Sales Volume by Type (2020-2025) & (MT)
Table 9. Global Quetiapine Fumarate Sales Volume by Type (2026-2031) & (MT)
Table 10. Global Quetiapine Fumarate Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Quetiapine Fumarate Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Quetiapine Fumarate Sales Volume by Application (2020-2025) & (MT)
Table 13. Global Quetiapine Fumarate Sales Volume by Application (2026-2031) & (MT)
Table 14. Global Quetiapine Fumarate Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Quetiapine Fumarate Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Quetiapine Fumarate Sales by Manufacturer (2020-2025) & (MT)
Table 17. Global Quetiapine Fumarate Sales Share by Manufacturer (2020-2025)
Table 18. Quetiapine Fumarate Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Quetiapine Fumarate Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Quetiapine Fumarate Price (2020-2025) & (USD/Kg)
Table 21. Ranking of Global Top Quetiapine Fumarate Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Quetiapine Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Quetiapine Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quetiapine Fumarate as of 2024)
Table 24. Quetiapine Fumarate Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Quetiapine Fumarate Market
Table 26. Manufacturers Quetiapine Fumarate Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. AstraZeneca Company Information
Table 29. AstraZeneca Description and Business Overview
Table 30. AstraZeneca Quetiapine Fumarate Product
Table 31. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 32. AstraZeneca Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 33. AstraZeneca Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 34. AstraZeneca Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 35. AstraZeneca Recent Developments
Table 36. Intas Company Information
Table 37. Intas Description and Business Overview
Table 38. Intas Quetiapine Fumarate Product
Table 39. Intas Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 40. Intas Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 41. Intas Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 42. Intas Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 43. Intas Recent Developments
Table 44. TAPI Company Information
Table 45. TAPI Description and Business Overview
Table 46. TAPI Quetiapine Fumarate Product
Table 47. TAPI Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 48. TAPI Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 49. TAPI Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 50. TAPI Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 51. TAPI Recent Developments
Table 52. Accord Company Information
Table 53. Accord Description and Business Overview
Table 54. Accord Quetiapine Fumarate Product
Table 55. Accord Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 56. Accord Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 57. Accord Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 58. Accord Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 59. Accord Recent Developments
Table 60. Hexal Company Information
Table 61. Hexal Description and Business Overview
Table 62. Hexal Quetiapine Fumarate Product
Table 63. Hexal Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 64. Hexal Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 65. Hexal Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 66. Hexal Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 67. Hexal Recent Developments
Table 68. Dr.Reddy's Company Information
Table 69. Dr.Reddy's Description and Business Overview
Table 70. Dr.Reddy's Quetiapine Fumarate Product
Table 71. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 72. Dr.Reddy's Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 73. Dr.Reddy's Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 74. Dr.Reddy's Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 75. Dr.Reddy's Recent Developments
Table 76. Lupin Company Information
Table 77. Lupin Description and Business Overview
Table 78. Lupin Quetiapine Fumarate Product
Table 79. Lupin Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Lupin Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 81. Lupin Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 82. Lupin Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 83. Lupin Recent Developments
Table 84. Sun Pharmaceutical Company Information
Table 85. Sun Pharmaceutical Description and Business Overview
Table 86. Sun Pharmaceutical Quetiapine Fumarate Product
Table 87. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Sun Pharmaceutical Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 89. Sun Pharmaceutical Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 90. Sun Pharmaceutical Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 91. Sun Pharmaceutical Recent Developments
Table 92. Hunan Dongting Pharm Company Information
Table 93. Hunan Dongting Pharm Description and Business Overview
Table 94. Hunan Dongting Pharm Quetiapine Fumarate Product
Table 95. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 96. Hunan Dongting Pharm Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 97. Hunan Dongting Pharm Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 98. Hunan Dongting Pharm Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 99. Hunan Dongting Pharm Recent Developments
Table 100. SuZhou NO.4 Phamaceutical Factory Company Information
Table 101. SuZhou NO.4 Phamaceutical Factory Description and Business Overview
Table 102. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product
Table 103. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 104. SuZhou NO.4 Phamaceutical Factory Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 105. SuZhou NO.4 Phamaceutical Factory Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 106. SuZhou NO.4 Phamaceutical Factory Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 107. SuZhou NO.4 Phamaceutical Factory Recent Developments
Table 108. Fuan Pharmaceutical Company Information
Table 109. Fuan Pharmaceutical Description and Business Overview
Table 110. Fuan Pharmaceutical Quetiapine Fumarate Product
Table 111. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 112. Fuan Pharmaceutical Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 113. Fuan Pharmaceutical Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 114. Fuan Pharmaceutical Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 115. Fuan Pharmaceutical Recent Developments
Table 116. Zhejiang Supor Pharmaceuticals Company Information
Table 117. Zhejiang Supor Pharmaceuticals Description and Business Overview
Table 118. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product
Table 119. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Zhejiang Supor Pharmaceuticals Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 121. Zhejiang Supor Pharmaceuticals Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 122. Zhejiang Supor Pharmaceuticals Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 123. Zhejiang Supor Pharmaceuticals Recent Developments
Table 124. Zhejiang Huahai Pharmaceutical Company Information
Table 125. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 126. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product
Table 127. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Zhejiang Huahai Pharmaceutical Sales Proportion of Quetiapine Fumarate by Product in 2024
Table 129. Zhejiang Huahai Pharmaceutical Sales Proportion of Quetiapine Fumarate by Application in 2024
Table 130. Zhejiang Huahai Pharmaceutical Sales Proportion of Quetiapine Fumarate by Geographic Area in 2024
Table 131. Zhejiang Huahai Pharmaceutical Recent Developments
Table 132. North America Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 133. North America Quetiapine Fumarate Sales by Country (2026-2031) & (MT)
Table 134. North America Quetiapine Fumarate Revenue by Country (2020-2025) & (US$ Million)
Table 135. North America Quetiapine Fumarate Revenue by Country (2026-2031) & (US$ Million)
Table 136. North America Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 137. North America Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 138. Asia-Pacific Quetiapine Fumarate Sales by Region (2020-2025) & (MT)
Table 139. Asia-Pacific Quetiapine Fumarate Sales by Region (2026-2031) & (MT)
Table 140. Asia-Pacific Quetiapine Fumarate Revenue by Region (2020-2025) & (US$ Million)
Table 141. Asia-Pacific Quetiapine Fumarate Revenue by Region (2026-2031) & (US$ Million)
Table 142. Asia-Pacific Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 143. Asia-Pacific Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 144. Europe Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 145. Europe Quetiapine Fumarate Sales by Country (2026-2031) & (MT)
Table 146. Europe Quetiapine Fumarate Revenue by Country (2020-2025) & (US$ Million)
Table 147. Europe Quetiapine Fumarate Revenue by Country (2026-2031) & (US$ Million)
Table 148. Europe Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 149. Europe Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 150. Latin America Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 151. Latin America Quetiapine Fumarate Sales by Country (2026-2031) & (MT)
Table 152. Latin America Quetiapine Fumarate Revenue by Country (2020-2025) & (US$ Million)
Table 153. Latin America Quetiapine Fumarate Revenue by Country (2026-2031) & (US$ Million)
Table 154. Latin America Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 155. Latin America Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 156. Middle East and Africa Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 157. Middle East and Africa Quetiapine Fumarate Sales by Country (2026-2031) & (MT)
Table 158. Middle East and Africa Quetiapine Fumarate Revenue by Country (2020-2025) & (US$ Million)
Table 159. Middle East and Africa Quetiapine Fumarate Revenue by Country (2026-2031) & (US$ Million)
Table 160. Middle East and Africa Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 161. Middle East and Africa Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 162. Quetiapine Fumarate Key Raw Materials, Industry Status and Trend
Table 163. Quetiapine Fumarate Key Raw Materials and Upstream Suppliers
Table 164. Quetiapine Fumarate Clients Status and Trend
Table 165. Quetiapine Fumarate Typical Clients
Table 166. Quetiapine Fumarate Distributors
Table 167. Quetiapine Fumarate Market Trends
Table 168. Quetiapine Fumarate Market Drivers
Table 169. Quetiapine Fumarate Market Challenges
Table 170. Quetiapine Fumarate Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Quetiapine Fumarate Product Picture
Figure 2. Global Quetiapine Fumarate Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Quetiapine Fumarate Sales Market Share by Type in 2024 & 2031
Figure 4. Immediate Release Tablets Product Picture
Figure 5. Extended Release Tablets Product Picture
Figure 6. Global Quetiapine Fumarate Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Quetiapine Fumarate Sales Market Share by Application in 2024 & 2031
Figure 8. Adult
Figure 9. Others
Figure 10. Quetiapine Fumarate Report Years Considered
Figure 11. Global Quetiapine Fumarate Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Quetiapine Fumarate Market Size 2020-2031 (US$ Million)
Figure 13. Global Quetiapine Fumarate Sales 2020-2031 (MT)
Figure 14. Global Quetiapine Fumarate Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Quetiapine Fumarate Revenue Market Share by Region (2020-2031)
Figure 16. Global Quetiapine Fumarate Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Quetiapine Fumarate Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Quetiapine Fumarate Average Selling Price (ASP) by Type (2020-2025) & (USD/Kg)
Figure 19. Global Quetiapine Fumarate Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Quetiapine Fumarate Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Quetiapine Fumarate Average Selling Price (ASP) by Application (2020-2025) & (USD/Kg)
Figure 22. Immediate Release Tablets of Quetiapine Fumarate Revenue Market Share by Application, 2024 VS 2031
Figure 23. Extended Release Tablets of Quetiapine Fumarate Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Quetiapine Fumarate Sales Share by Manufacturer in 2024
Figure 25. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Immediate Release Tablets Market Sales Proportion by Manufacturer in 2024
Figure 27. Extended Release Tablets Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Quetiapine Fumarate Revenue 2020-2031 (US$ Million)
Figure 29. North America Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 30. North America Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Quetiapine Fumarate Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Quetiapine Fumarate Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Quetiapine Fumarate Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 36. Europe Quetiapine Fumarate Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Quetiapine Fumarate Sales Market Share by Country (2020-2031)
Figure 38. Europe Quetiapine Fumarate Revenue Market Share by Country (2020-2031)
Figure 39. Europe Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 40. Europe Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 41. Latin America Quetiapine Fumarate Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Quetiapine Fumarate Sales Market Share by Country (2020-2031)
Figure 43. Latin America Quetiapine Fumarate Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 45. Latin America Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Quetiapine Fumarate Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Quetiapine Fumarate Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Quetiapine Fumarate Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 51. Quetiapine Fumarate Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Quetiapine Fumarate Raw Materials by Region in 2024
Figure 53. Quetiapine Fumarate Distribution Channels
Figure 54. Global Quetiapine Fumarate Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Quetiapine Fumarate Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232